全科医生对妊娠并发症后婴儿端粒长度筛查的看法:定性分析
本研究对澳大利亚阿德莱德12名全科医生进行半结构化访谈,定性探讨其对妊娠并发症后婴儿端粒长度筛查可行性与接受度的看法。全科医生总体支持潜在的新生儿端粒筛查,尤其认可可嵌入现有产前保健的唾液检测,但需克服知识缺乏、伦理考量及时间与财务限制等挑战。
要点
- 全科医生总体支持妊娠并发症后婴儿端粒长度筛查,尤其认可唾液检测嵌入产前保健。
- 伦理障碍包括代儿童知情同意、父母内疚感及医疗保险影响,健康促进视角为促进因素。
- 实践障碍包括识别合格筛查者的困难、服务提供者间沟通、时间与财务限制。
核心结论
- 全科医生总体支持潜在的新生儿端粒筛查,尤其认可可嵌入现有产前保健的唾液检测。
- 在将此类检测引入实践前,需克服知识缺乏、伦理考量及时间与财务限制等挑战。
研究设计与样本
- 对澳大利亚南澳大利亚州阿德莱德都会区12名全科医生进行半结构化访谈的定性研究。
- 访谈录音后逐字转录,并进行编码和主题分析。
主要发现
- 分析生成两个主题:伦理考量和实践考量。
- 伦理考量中,障碍包括代儿童知情同意、父母内疚感和医疗保险影响,健康促进视角为促进因素。
- 实践考量中,障碍包括识别合格筛查者的困难、维持服务提供者间医疗沟通以及时间和财务限制,将端粒筛查与现有筛查关联可促进接受度。
临床怎么用
- 全科医生可考虑将端粒长度唾液检测嵌入现有产前保健流程以提高接受度。
- 实施前需解决全科医生知识缺乏、伦理问题及时间与财务限制等障碍。
局限性
- 研究仅纳入澳大利亚阿德莱德都会区12名全科医生,为定性研究。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnancy complications can impact the mother and child's health in the short and longterm resulting in an increased risk of chronic disease later in life. Telomere length is a biomarker of future cardiometabolic diseases and may offer a novel way of identifying offspring most at risk for future chronic diseases. OBJECTIVE(S): To qualitatively explore General Practitioners' (GPs) perspectives on the feasibility and uptake for recommending a telomere screening test in children who were born after a pregnancy complication. METHODS: Twelve semi-structured interviews were conducted with GPs within metropolitan Adelaide, South Australia. Interviews were audio recorded, transcribed verbatim, and analysed for codes and themes. RESULTS: Two themes were generated: ethical considerations and practical considerations. Ethically, the GP participants discussed barriers including consenting on behalf of a child, parental guilt, and the impact of health insurance, whereas viewing it for health promotion was a facilitator. For practical considerations, barriers included the difficulty in identifying people eligible for screening, maintaining medical communication between service providers, and time and financial constraints, whereas linking screening for telomere length with existing screening would facilitate uptake. CONCLUSIONS: GPs were generally supportive of potential telomere screening in infants, particularly via a saliva test that could be embedded in current antenatal care. However, several challenges, such as lack of knowledge, ethical considerations, and time and financial constraints, need to be overcome before such a test could be implemented into practice. Around one fifth of women experience a pregnancy complication that places their infants at higher risk for a range of chronic diseases in later life. Although not all infants will have adverse health outcomes, it is important to identify offspring early in life who may be at higher risk. Telomere length is a biomarker of future chronic disease that can be obtained from blood or saliva. Whether telomere length might be useful as a screening tool in newborns born from a pregnancy complication has not been investigated. This study qualitatively explores the perspectives of 12 general practitioners in Adelaide, Australia, on the feasibility and uptake of telomere screening in children born after a pregnancy complication. Overall, general practitioners were generally supportive of potential telomere screening in infants, particularly via a saliva test that could be embedded in current antenatal care. However, several challenges, such as lack of knowledge, ethical considerations, and time and financial constraints, need to be overcome before such a test could be implemented into practice. Study findings contribute to the limited knowledge assessing follow-up of screening after pregnancy within Australia and internationally and provide novel findings on a potential new screening tool that could be considered early in life.
引用
- Puglisi CJ, McDonough J, Bianco-Miotto T, et al. General Practitioners perspectives on infant telomere length screening after a pregnancy complication: a qualitative analysis. Fam Pract. 2024. PMID: 37262296. doi:10.1093/fampra/cmad064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。